BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37741105)

  • 1. Predictors of All-Cause Mortality After Successful Transcatheter Aortic Valve Implantation in Patients With Atrial Fibrillation.
    Yamamoto M; Hayashida K; Hengstenberg C; Watanabe Y; Van Mieghem NM; Jin J; Saito S; Valgimigli M; Nicolas J; Mehran R; Moreno R; Kimura T; Chen C; Unverdorben M; Dangas GD
    Am J Cardiol; 2023 Nov; 207():150-158. PubMed ID: 37741105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial.
    Van Mieghem NM; Unverdorben M; Valgimigli M; Mehran R; Boersma E; Baber U; Hengstenberg C; Shi M; Chen C; Saito S; Veltkamp R; Vranckx P; Dangas GD
    Am Heart J; 2018 Nov; 205():63-69. PubMed ID: 30172099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF Trial.
    Hengstenberg C; Van Mieghem NM; Wang R; Ye X; Shi L; Guo S; Chen C; Jin J; Ye X; Dangas G; Unverdorben M
    Am J Cardiol; 2023 Dec; 209():212-219. PubMed ID: 37848174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edoxaban vs. Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement in Japanese Patients - A Subanalysis of the ENVISAGE-TAVI AF Trial.
    Watanabe Y; Hayashida K; Yamamoto M; Yamanaka F; Yamasaki K; Naganuma T; Ohno Y; Yamawaki M; Morioka N; Mizutani K; Tada N; Ueno H; Nishina H; Izumo M; Nakajima Y; Ando K; Takagi K; Kimura T; Sugio K; Dangas G; Van Mieghem NM; Hengstenberg C; Chen C; Jin J; Unverdorben M; Saito S
    Circ J; 2022 Oct; 86(11):1756-1763. PubMed ID: 35965066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation.
    Stortecky S; Buellesfeld L; Wenaweser P; Heg D; Pilgrim T; Khattab AA; Gloekler S; Huber C; Nietlispach F; Meier B; Jüni P; Windecker S
    Circ Cardiovasc Interv; 2013 Feb; 6(1):77-84. PubMed ID: 23386662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
    Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
    JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
    Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
    Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the CHA
    Orvin K; Levi A; Landes U; Bental T; Sagie A; Shapira Y; Vaknin-Assa H; Assali A; Kornowski R
    Am J Cardiol; 2018 Jan; 121(2):241-248. PubMed ID: 29157734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
    Van Mieghem NM; Unverdorben M; Hengstenberg C; Möllmann H; Mehran R; López-Otero D; Nombela-Franco L; Moreno R; Nordbeck P; Thiele H; Lang I; Zamorano JL; Shawl F; Yamamoto M; Watanabe Y; Hayashida K; Hambrecht R; Meincke F; Vranckx P; Jin J; Boersma E; Rodés-Cabau J; Ohlmann P; Capranzano P; Kim HS; Pilgrim T; Anderson R; Baber U; Duggal A; Laeis P; Lanz H; Chen C; Valgimigli M; Veltkamp R; Saito S; Dangas GD;
    N Engl J Med; 2021 Dec; 385(23):2150-2160. PubMed ID: 34449183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk.
    Kolkailah AA; Doukky R; Pelletier MP; Volgman AS; Kaneko T; Nabhan AF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD013319. PubMed ID: 31860123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in Antithrombotic Therapy and Clinical Outcomes in Patients With Preexisting Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Sherwood MW; Gupta A; Vemulapalli S; Li Z; Piccini J; Harrison JK; Dai D; Vora AN; Mack MJ; Holmes DR; Rumsfeld JS; Cohen DJ; Thourani VH; Kirtane AJ; Peterson ED
    Circ Cardiovasc Interv; 2021 Apr; 14(4):e009963. PubMed ID: 33877866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis.
    Swift SL; Puehler T; Misso K; Lang SH; Forbes C; Kleijnen J; Danner M; Kuhn C; Haneya A; Seoudy H; Cremer J; Frey N; Lutter G; Wolff R; Scheibler F; Wehkamp K; Frank D
    BMJ Open; 2021 Dec; 11(12):e054222. PubMed ID: 34873012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement.
    Mentias A; Saad M; Girotra S; Desai M; Elbadawi A; Briasoulis A; Alvarez P; Alqasrawi M; Giudici M; Panaich S; Horwitz PA; Jneid H; Kapadia S; Vaughan Sarrazin M
    JACC Cardiovasc Interv; 2019 Nov; 12(21):2119-2129. PubMed ID: 31629743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.
    Kosmidou I; Liu Y; Alu MC; Liu M; Madhavan M; Chakravarty T; Makkar R; Thourani VH; Biviano A; Kodali S; Leon MB
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1580-1589. PubMed ID: 31439338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Atrial Fibrillation on Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): The K-TAVI Registry.
    Lee SY; Choi KH; Park TK; Kim J; Kim EK; Park SJ; Park SW; Gwon HC; Chang K; Yu CW; Kim J; Choi YJ; Chae IH; Lee JH; Kim JH; Park JS; Kim WJ; Yoon YW; Ahn TH; Lee SR; Choi BJ; Yang TH; Choi CU; Hur SH; Oh SJ; Lee HC; Park H; Kim HS; Choi SH
    Yonsei Med J; 2023 Jul; 64(7):413-422. PubMed ID: 37365735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation, stroke, and mortality rates after transcatheter aortic valve implantation.
    Yankelson L; Steinvil A; Gershovitz L; Leshem-Rubinow E; Furer A; Viskin S; Keren G; Banai S; Finkelstein A
    Am J Cardiol; 2014 Dec; 114(12):1861-6. PubMed ID: 25438914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left atrial appendage thrombus and cerebrovascular events post-transcatheter aortic valve implantation.
    van Wiechen MP; Faure ME; Hokken TW; Ooms JF; de Ronde-Tillmans MJ; Hirsch A; Daemen J; de Jaegere PP; Budde RPJ; Van Mieghem NM
    Eur Heart J Cardiovasc Imaging; 2022 Sep; 23(10):1345-1353. PubMed ID: 34322706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.